The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
Sirona Capital invests in the future of healthcare innovation and therapeutics.
Venture capitalsironacap.comSince 2025-10-14
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Kailera Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people living with obesity | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $600M | 2025-10-14 | [ PART ] |
No sector on record.